The Prevalence of Symptomatology and Risk Factors in Mental Health in Mexico: The 2016–17 ENCODAT Cohort
-
Published:2023-02-10
Issue:4
Volume:20
Page:3109
-
ISSN:1660-4601
-
Container-title:International Journal of Environmental Research and Public Health
-
language:en
-
Short-container-title:IJERPH
Author:
Medina-Mora María Elena123ORCID, Genis-Mendoza Alma Delia45, Villatoro Velázquez Jorge Ameth16ORCID, Bustos-Gamiño Marycarmen6, Bautista Clara Fleiz16, Camarena Beatriz7ORCID, Martínez-Magaña José Jaime4ORCID, Nicolini Humberto4ORCID
Affiliation:
1. Global Studies Seminar, School of Medicine, National Autonomous University of Mexico (UNAM), Mexico City 04510, Mexico 2. Director, School of Psychology, National Autonomous University of Mexico (UNAM), Mexico City 04510, Mexico 3. Centro de Investigación en Salud Mental Global INPRFM UNAM, Mexico City 04510, Mexico 4. Psychiatric and Neurodegenerative Disease Genomics Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City 14610, Mexico 5. Juan N. Navarro Children’s Psychiatric Hospital, Psychiatric Care Services, Mexico City 14080, Mexico 6. Data Analysis and Survey Unit, Ramón de la Fuente Muñiz National Institute of Psychiatry (INPRFM), Mexico City 14370, Mexico 7. Department of Pharmacogenetics, Ramón de la Fuente Muñiz National Institute of Psychiatry (INPRFM), Mexico City 14370, Mexico
Abstract
There is little recent information about the prevalence of symptomatology of mental health disorders in representative population samples in Mexico. To determine the prevalence of mental health symptoms in Mexico and its comorbidity with tobacco, alcohol, and drug use disorder (SUD), we used the 2016–17 National Survey of Drug, Alcohol, and Tobacco Use (Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco, ENCODAT 2016–2017). The data were collected from households using a cross-sectional, stratified, multistage design, with a confidence level of 90% and a response rate of 73.6%. The final sample included 56,877 completed interviews of individuals aged 12–65, with a subsample of 13,130 who answered the section on mental health. Symptoms of mania and hypomania (7.9%), depression (6.4%), and post-traumatic stress (5.7%) were the three main problems reported. Of this subsample, 56.7% reported using a legal or illegal drug without SUD, 5.4% reported SUD at one time on alcohol, 0.8% on tobacco, and 1.3% on medical or illegal drugs, 15.9% reported symptoms related to mental health, and 2.9% comorbidity. The prevalence found is consistent with those reported in previous studies, except for an increase in post-traumatic stress, which is consistent with the country’s increase in trauma.
Funder
Instituto Nacional de Medicina Genómica Comisión Nacional de Ciencia y Tecnología Comisión Nacional Contra las Adicciones
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference28 articles.
1. Lifetime Prevalence and Age-of-Onset Distributions of MentalmDisorders in the World Health Organization’s World Mental Health Survey Initiative;Kessler;World Psychiatry,2007 2. Prevalencia de Trastornos Mentales y Uso de Servicios: Resultados de La Encuesta Nacional de Epidemiología Psiquiátrica En México;Borges;Salud Ment.,2003 3. Sex Differences in the Prevalence and Severity of Psychiatric Disorders in Adolescents in Mexico City;Benjet;Ment. Health,2009 4. Depressive Symptoms and Coverage of Diagnosis and Treatment of Depression in the Mexican Population;Salud Pública México,2020 5. Ramón de la Fuente Muñiz National Institute of Psychiatry (INPRFM), National Institute of Public Health (INSP), National Commission against Addictions (CONADIC), Ministry of Health (SSA), Villatoro-Velázquez, J.A., Resendiz-Escobar, E., Mujica-Salazar, A., Breton-Cirett, M., Canas-Martinez, V., and Soto-Hernandez, I. (2017). National Survey of Drug, Alcohol and Tobacco Consumption 2016–2017: Drug Report.
|
|